Skip to main content

JANUS HENDERSON GROUP PLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1274173 LONDON, X0

Position in TVTX

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$339,275,898
-$62,355,753 QoQ
Shares Held
11,419,586
+8.6% QoQ
Ownership
12.1%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 97% None 3%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. TVTX ranks #10 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TVTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $339,275,898 11,419,586
2025-12-31 $401,631,651 10,511,166
2025-09-30 $253,331,873 10,599,660
2025-09-30 $253,331,874 10,599,660
2025-06-30 $141,210,794 9,541,270
2025-03-31 $134,912,904 7,528,622
2024-12-31 $70,701,368 4,058,632
2024-09-30 $445,063 31,813
2024-06-30 $261,502 31,813
2024-03-31 $248,115 32,181
2023-12-31 $289,297 32,180
2023-09-30 $288,180 32,235
2023-06-30 $107,012,656 6,966,970
2023-03-31 $153,962,332 6,845,813
2022-12-31 $107,069,723 5,091,285
2022-09-30 $96,403,629 3,912,485
2022-06-30 $97,856,028 4,038,631
2022-03-31 $106,998,250 4,152,047
2021-12-31 $124,661,544 4,016,158
2021-09-30 $97,559,544 4,023,074
2021-06-30 $56,975,598 3,905,113
2021-03-31 $103,639,383 4,150,556
2020-12-31 $111,297,237 4,083,553
2020-09-30 RTRX 3,657,157
2020-06-30 RTRX 2,912,069
2020-03-31 RTRX 159,195